Cargando…

No evidence for cardiotoxicity of miltefosine()

Detalles Bibliográficos
Autor principal: Dorlo, Thomas P.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263634/
https://www.ncbi.nlm.nih.gov/pubmed/35654652
http://dx.doi.org/10.1016/j.abd.2022.03.002
_version_ 1784742780039331840
author Dorlo, Thomas P.C.
author_facet Dorlo, Thomas P.C.
author_sort Dorlo, Thomas P.C.
collection PubMed
description
format Online
Article
Text
id pubmed-9263634
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-92636342022-07-11 No evidence for cardiotoxicity of miltefosine() Dorlo, Thomas P.C. An Bras Dermatol Correspondence Sociedade Brasileira de Dermatologia 2022 2022-05-30 /pmc/articles/PMC9263634/ /pubmed/35654652 http://dx.doi.org/10.1016/j.abd.2022.03.002 Text en © 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Correspondence
Dorlo, Thomas P.C.
No evidence for cardiotoxicity of miltefosine()
title No evidence for cardiotoxicity of miltefosine()
title_full No evidence for cardiotoxicity of miltefosine()
title_fullStr No evidence for cardiotoxicity of miltefosine()
title_full_unstemmed No evidence for cardiotoxicity of miltefosine()
title_short No evidence for cardiotoxicity of miltefosine()
title_sort no evidence for cardiotoxicity of miltefosine()
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263634/
https://www.ncbi.nlm.nih.gov/pubmed/35654652
http://dx.doi.org/10.1016/j.abd.2022.03.002
work_keys_str_mv AT dorlothomaspc noevidenceforcardiotoxicityofmiltefosine